Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Harmonizing the Paradigm With the Data in Stable Coronary Artery Disease: A Review and Viewpoint.

Mitchell JD, Brown DL.

J Am Heart Assoc. 2017 Nov 13;6(11). pii: e007006. doi: 10.1161/JAHA.117.007006. Review. No abstract available.

2.

Comparison of 3 Predictive Clinical Risk Scores in 603 Patients with Stable Coronary Artery Disease.

Aceña Á, Martín-Mariscal ML, Tarín N, Cristóbal C, Huelmos A, Pello A, Carda R, Alonso J, Lorenzo Ó, Mahíllo-Fernández I, Tuñón J.

Tex Heart Inst J. 2017 Aug 1;44(4):239-244. doi: 10.14503/THIJ-15-5643. eCollection 2017 Aug.

3.

Does modern medicine increase life-expectancy: Quest for the Moon Rabbit?

Mishra S.

Indian Heart J. 2016 Jan-Feb;68(1):19-27. doi: 10.1016/j.ihj.2016.01.003. Epub 2016 Jan 18.

4.

Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model.

Wang SL, Wang CL, Wang PL, Xu H, Chen KJ, Shi DZ.

Evid Based Complement Alternat Med. 2015;2015:639267. doi: 10.1155/2015/639267. Epub 2015 Oct 1.

5.

Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.

Werdan K, Ebelt H, Nuding S, Höpfner F, Stöckl G, Müller-Werdan U.

Adv Ther. 2015 Feb;32(2):120-37. doi: 10.1007/s12325-015-0182-8. Epub 2015 Feb 17.

6.

Initial reduction of oxidative stress by angiotensin receptor blocker contributes long term outcomes after percutaneous coronary intervention.

Noro T, Takehara N, Sumitomo K, Takeuchi T, Ishii Y, Kato J, Kawabe J, Hasebe N.

Am J Cardiovasc Dis. 2014 Dec 29;4(4):159-67. eCollection 2014.

7.

Investigation route of the coronary patient in the public health system in Curitiba, São Paulo and in InCor--IMPACT study.

Cerci JJ, Trindade E, Preto D, Cerci RJ, Lemos PA, Cesar LA, Preto L, Stinghen L, Martinez C, Meneghetti JC.

Arq Bras Cardiol. 2014 Sep;103(3):192-200. Epub 2014 Jul 29. English, Portuguese.

8.

Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).

Brown TM, Voeks JH, Bittner V, Brenner DA, Cushman M, Goff DC Jr, Glasser S, Muntner P, Tabereaux PB, Safford MM.

J Am Coll Cardiol. 2014 Apr 29;63(16):1626-33. doi: 10.1016/j.jacc.2013.12.042. Epub 2014 Feb 26.

9.

Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.

Izzo P, Macchi A, De Gennaro L, Gaglione A, Di Biase M, Brunetti ND.

Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):158-69. doi: 10.1177/2048872612449111.

10.

An Overview on Coronary Heart Disease (A Comparative Evaluation of Turkey and Europe) and Cost-effectiveness of Diagnostic Strategies.

Taşçı C, Ozçelik N.

Mol Imaging Radionucl Ther. 2011 Dec;20(3):75-93. doi: 10.4274/MIRT.33. Epub 2011 Dec 1.

11.

Drug-eluting coronary stents - focus on improved patient outcomes.

Jaffery Z, Prasad A, Lee JH, White CJ.

Patient Relat Outcome Meas. 2011 Jul;2:161-74. doi: 10.2147/PROM.S24796. Epub 2011 Sep 22.

12.

Medical angioplasty - hope and expectations: an optimistic overview.

Abdul-Mohsen MF.

J Family Community Med. 2011 Sep;18(3):101-10. doi: 10.4103/2230-8229.90007.

13.

Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic.

Leuschner F, Nahrendorf M.

Circ Res. 2011 Mar 4;108(5):593-606. doi: 10.1161/CIRCRESAHA.110.232678. Review.

14.

Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).

Devlin G, Reynolds HR, Mark DB, Rankin JM, Carvalho AC, Vozzi C, Sopko G, Caramori P, Džavík V, Ragosta M, Forman SA, Lamas GA, Hochman JS.

Am Heart J. 2011 Jan;161(1):84-90. doi: 10.1016/j.ahj.2010.09.009.

15.

The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.

Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S, Sopko G, Ramires JA, Schneider D, Frye RL; Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group.

Circulation. 2009 Dec 22;120(25):2529-40. doi: 10.1161/CIRCULATIONAHA.109.913111. Epub 2009 Nov 17. Erratum in: Circulation. 2010 Mar 30;121(12):e254.

16.

Appropriateness of diagnosis of unstable angina pectoris in patients referred for coronary arteriography.

Goldberg A, Yalonetsky S, Kopeliovich M, Azzam Z, Markiewicz W.

Exp Clin Cardiol. 2008 Fall;13(3):133-7.

17.

High probability of disease in angina pectoris patients: is clinical estimation reliable?

Høilund-Carlsen PF, Johansen A, Vach W, Christensen HW, Møldrup M, Haghfelt T.

Can J Cardiol. 2007 Jun;23(8):641-7.

18.

The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease.

Charytan D, Kuntz RE.

Kidney Int. 2006 Dec;70(11):2021-30. Epub 2006 Oct 18.

19.

Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study.

Daly CA, De Stavola B, Sendon JL, Tavazzi L, Boersma E, Clemens F, Danchin N, Delahaye F, Gitt A, Julian D, Mulcahy D, Ruzyllo W, Thygesen K, Verheugt F, Fox KM; Euro Heart Survey Investigators.

BMJ. 2006 Feb 4;332(7536):262-7. Epub 2006 Jan 13.

20.

Will drug-eluting stents replace coronary artery bypass surgery?

Reul RM.

Tex Heart Inst J. 2005;32(3):323-30. Review.

Supplemental Content

Support Center